GSK to settle 80,000 Zantac cases for up to $2.2 billion
The deal settles 80,000 US court cases related to allegations that Zantac was contaminated with a suspected carcinogen.
WJET Erie on MSN3d
Drugmaker to settle nearly 80K Zantac lawsuits for up to $2.2 billion
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
Wall Street Journal4d
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
The British pharmaceutical giant said Wednesday that it had struck agreements with 10 plaintiff firms aimed at resolving 93%, or about 80,000, of pending Zantac lawsuits in the country for up to ...
Zantac Maker GSK Says It Reaches $2.3 Bn Settlement In US
British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
MarketWatch4d
GSK to Resolve 93% of U.S. State Court Zantac Product Liability Cases for Up to $2.2B
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
The Financial Times4d
GSK reaches $2.2bn heartburn medication Zantac settlement in US
GSK has reached a $2.2bn settlement to resolve the vast majority of cases linked to its heartburn medicine Zantac, in a move that will help assuage legal concerns overhanging the UK drugmaker.
Reuters25d
Boehringer Ingelheim faces second hung jury in Chicago Zantac trial
Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters ...
Morningstar4d
GSK Reached Agreements With 10 Plaintiff Firms Over Zantac Litigation
GSK agreed to pay $2.2 billion to 10 plaintiff firms over liability cases related to its discontinued heartburn medicine Zantac allegedly causing cancer. The British pharmaceutical giant said ...
Reuters25d
GSK settles two California lawsuits related to heartburn drug Zantac
Sept 18 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer.
Yahoo Finance4d
GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges
On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% ...
Daily Breeze4d
GSK to settle 80,000 Zantac cases for up to $2.2 billion
GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen.
CNN3d
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...